The clinical trial at Mizzou marks the latest human trial involving radioisotopes to treat cancer.

Researchers developed lab-grown human spinal cord organoids to model different types of spinal cord injuries and test new therapy.

Researchers seek FDA approval for their treatment that shows significant potential for tackling glioblastoma.